|Acquired by||Bio-Rad Laboratories|
|Series A, 12/2010 ||$3M|
|Series A, 9/2011 ||$5M|
|Grant, 9/2012 ||$4.5M|
|Series B, 10/2012 ||$10M|
GnuBIO is a leading developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the GnuBIO’s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplification, DNA sequencing and analysis. GnuBIO’s cutting-edge platform provides a single user interface, and a single step process, which rapidly produces results to hours versus days.